CSIMarket
 


Fibrogen Inc   (FGEN)
Other Ticker:  
 
 

Fibrogen Inc Accounts Receivables Turnover Ratio from the third quarter 2023 to the third quarter 2022

Quarterly Results, Trends, Rankings, Statistics


Fibrogen Inc 's ability to collect accounts receivable sequentially worsen to 6.79, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Fibrogen Inc 's Average receivable collection period in the Sep 30 2023 quarter, has increased to 54 days, from 52 days, in the Jun 30 2023 quarter.

If we take a look into Healthcare sector 253 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2023 from 1951 to 1994.

What is Receivable Turnover Ratio?
What is Fibrogen Inc Selling?


What is Receivable Turnover Ratio?




FGEN Receivables Turnover Ratio (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Receivable Change 106.77 % -23.75 % -59.77 % -6.33 % -57.42 %
Y / Y Revenue Change 155.06 % 48.69 % -40.55 % 107.74 % -89.91 %
Receivable Turnover Ratio (TTM) 6.79 6.98 5.6 5.16 4.46
FGEN's Total Ranking # 1994 # 1951 # 2489 # 2714 # 2041
Average receivable collection period 54 52 65 71 82
Seq. Receivable Change 23.81 % 45 % 8.31 % 6.33 % -54.34 %
Seq. Revenue Change -9.44 % 22.56 % 5.22 % 118.4 % -47.21 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 94
Healthcare Sector # 254
Overall Market # 1994

Receivable Turnover Ratio Statistics
High Average Low
17.06 9.42 3.27
(Dec 31 2019)   (Jun 30 2020)






Financial Statements
Fibrogen Inc 's Accounts Receivable $ 32 Millions Visit FGEN's Balance sheet
Fibrogen Inc 's Sales TTM $ 155 Millions Visit FGEN's Income Statement
Where are FGEN's Sales coming from? Visit FGEN's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
FGEN's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover
Accounts Receivable Turnover for FGEN's Competitors
Receivables Turnover Ratio for FGEN's Suppliers
Accounts Receivables Turnover Ratio for FGEN's Customers

You may also want to know
FGEN's Growth Rates FGEN's Roa FGEN's Inventory Turnover Ratio FGEN's Dividend Comparisons
FGEN's Profitability Ratios FGEN's Roi FGEN's Asset Turnover Ratio FGEN's Dividend Growth
FGEN's Valuation Ratios FGEN's Roe FGEN's Financial Strength Ratios FGEN's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2023 Receivable at quarter ending Sep 30 2023
Exact Sciences Corporation  13.39 $ 2,407.624  Millions$ 179.784  Millions
Icu Medical Inc  13.12 $ 2,247.910  Millions$ 171.300  Millions
Milestone Scientific Inc   13.11 $ 9.788  Millions$ 0.747  Millions
Dmk Pharmaceuticals Corporation  12.53 $ 3.525  Millions$ 0.281  Millions
Ideaya Biosciences Inc   12.46 $ 23.484  Millions$ 1.886  Millions
Nutriband Inc   12.45 $ 2.088  Millions$ 0.168  Millions
Precipio inc   12.45 $ 13.259  Millions$ 1.065  Millions
Nanovibronix Inc  12.43 $ 1.203  Millions$ 0.097  Millions
Revance Therapeutics Inc   12.38 $ 214.162  Millions$ 17.292  Millions
Equillium Inc   12.38 $ 42.632  Millions$ 3.444  Millions
Amylyx Pharmaceuticals Inc   12.30 $ 294.222  Millions$ 23.922  Millions
Caribou Biosciences Inc   12.19 $ 34.611  Millions$ 2.840  Millions
Teladoc Health Inc   12.17 $ 2,579.597  Millions$ 211.896  Millions
Reflect Scientific Inc   12.16 $ 1.370  Millions$ 0.113  Millions
International Stem Cell Corporation  12.16 $ 8.330  Millions$ 0.685  Millions
Merus N v   12.11 $ 45.674  Millions$ 3.773  Millions
Rockwell Medical inc   11.76 $ 79.550  Millions$ 6.763  Millions
Tg Therapeutics Inc   11.60 $ 189.773  Millions$ 16.357  Millions
Sunlink Health Systems Inc   11.57 $ 45.936  Millions$ 3.971  Millions
Surmodics Inc  11.49 $ 133.718  Millions$ 11.635  Millions
Travere Therapeutics Inc   11.46 $ 209.653  Millions$ 18.288  Millions
Zomedica Corp   11.36 $ 22.049  Millions$ 1.941  Millions
Integrated Biopharma Inc  11.32 $ 50.567  Millions$ 4.469  Millions
Eton Pharmaceuticals Inc   11.28 $ 31.887  Millions$ 2.826  Millions
National Healthcare Corp  10.85 $ 1,105.183  Millions$ 101.821  Millions
Option Care Health Inc   10.83 $ 4,204.399  Millions$ 388.052  Millions
The Oncology Institute Inc   10.75 $ 490.934  Millions$ 45.654  Millions
Traws Pharma inc   10.72 $ 0.217  Millions$ 0.020  Millions
Semler Scientific inc   10.61 $ 66.922  Millions$ 6.306  Millions
Sunshine Biopharma Inc   10.54 $ 20.425  Millions$ 1.937  Millions

Date modified: 2023-11-07T13:07:54+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com